Indivior Lifts FY26 Revenue Outlook to $1.33B Midpoint
INDV has more than doubled off its 52-week low of $19.31.
Summary
Indivior raised its full-year 2026 revenue guidance to $1.295B–$1.365B, up from a prior midpoint of roughly $1.25B, following strong Q1 revenue growth of 19% and a Q2 revenue beat driven by Sublocade growth. The company also executed a $500M convertible note offering and buybacks. The CSO role was eliminated in May, and insider sales have continued. The new guidance range suggests at least 5% upside to the old consensus, forcing analysts to revise models higher.
At the time of this announcement, INDV was trading at $40.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $19.31 to $42.81. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.